Mike Barnes

Allowing medical marijuana to be prescribed on the National Health Service (NHS) for chronic pain could save the national healthcare provider nearly £4 billion annually ($5.19 billion), new research reveals. The independent analysis of the economic case for prescribing medical cannabis on the NHS...

The last few years have brought many changes to cannabis laws across Europe. Here are some of the latest cannabis developments from the United Kingdom, The Netherlands and Poland. UK Experts Raise Concerns About Two Trials On Medical Marijuana And Epilepsy University of College London is preparing...

The UK’s Food Standards Agency (FSA) has significantly lowered the recommended daily intake of CBD from foods, after reviewing a joint position paper on the matter from the Advisory Committee on Novel Foods and Process and Committee on Toxicity (COT). Following the issued guidance,...

In the UK, a coalition of top industry groups, including the Cannabis Industry Council (CIC), Medical Cannabis Clinicians Society (MCCS), Volteface, and Maple Tree Consultants, launched a new campaign that aims to grant general practitioners (GPs) the authority to prescribe medical cannabis to...

The UK’s Centre for Medicinal Cannabis released its latest report Thursday. Titled “CBD in the UK: Towards a responsible innovative, and high-quality cannabidiol industry,” the report provides wide-ranging recommendations including amending existing out-of-date legislation;...

Here's a look at the top tickers trending on StockTwits.com Chelsea Therapeutics: FDA Approval confirmed On Tuesday, shares of Chelsea Therapeutics (NASDAQ: CHTP) were halted. An FDA decision for the company's Northera drug application was postponed from Friday due to severe weather. Shortly...